These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27861706)

  • 1. Predicting Risk of Cognitive Decline in Very Old Adults Using Three Models: The Framingham Stroke Risk Profile; the Cardiovascular Risk Factors, Aging, and Dementia Model; and Oxi-Inflammatory Biomarkers.
    Harrison SL; de Craen AJ; Kerse N; Teh R; Granic A; Davies K; Wesnes KA; den Elzen WP; Gussekloo J; Kirkwood TB; Robinson L; Jagger C; Siervo M; Stephan BC
    J Am Geriatr Soc; 2017 Feb; 65(2):381-389. PubMed ID: 27861706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores.
    Kaffashian S; Dugravot A; Elbaz A; Shipley MJ; Sabia S; Kivimäki M; Singh-Manoux A
    Neurology; 2013 Apr; 80(14):1300-6. PubMed ID: 23547265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Vascular Risk Scores and Cognitive Performance in a Diverse Cohort: The Multi-Ethnic Study of Atherosclerosis.
    Schaich CL; Yeboah J; Espeland MA; Baker LD; Ding J; Hayden KM; Sachs BC; Craft S; Rapp SR; Luchsinger JA; Fitzpatrick AL; Heckbert SR; Post WS; Burke GL; Allen NB; Hughes TM
    J Gerontol A Biol Sci Med Sci; 2022 Jun; 77(6):1208-1215. PubMed ID: 34216214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Vascular Risk Score and CAIDE Dementia Risk Score Predict Cognitive Function in the Northern Manhattan Study.
    Rundek T; Gardener H; Dias Saporta AS; Loewenstein DA; Duara R; Wright CB; Dong C; Levin B; Elkind MSV; Sacco RL
    J Alzheimers Dis; 2020; 73(3):1221-1231. PubMed ID: 31884476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third follow-up of the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) cohort investigating determinants of cognitive, physical, and psychosocial wellbeing among the oldest old: the CAIDE85+ study protocol.
    Barbera M; Kulmala J; Lisko I; Pietilä E; Rosenberg A; Hallikainen I; Hallikainen M; Laatikainen T; Lehtisalo J; Neuvonen E; Rusanen M; Soininen H; Tuomilehto J; Ngandu T; Solomon A; Kivipelto M
    BMC Geriatr; 2020 Jul; 20(1):238. PubMed ID: 32650731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining Vascular Risk Factors for Dementia and Dementia Risk Prediction Across Mid- to Later Life: The Framingham Heart Study.
    McGrath ER; Beiser AS; O'Donnell A; Himali JJ; Pase MP; Satizabal CL; Seshadri S
    Neurology; 2022 Jul; 99(2):e142-e153. PubMed ID: 35584926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Modified CAIDE Risk Score as a Screening Tool for Cognitive Impairment in Older Adults.
    Tolea MI; Heo J; Chrisphonte S; Galvin JE
    J Alzheimers Dis; 2021; 82(4):1755-1768. PubMed ID: 34219721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CAIDE Dementia Risk Score and the Honolulu-Asia Aging Study.
    Chosy EJ; Edland SD; Gross N; Meyer MJ; Liu CY; Launer LJ; White LR
    Dement Geriatr Cogn Disord; 2019; 48(3-4):164-171. PubMed ID: 31968337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating biomarkers and incident ischemic stroke in the Framingham Offspring Study.
    Shoamanesh A; Preis SR; Beiser AS; Kase CS; Wolf PA; Vasan RS; Benjamin EJ; Seshadri S; Romero JR
    Neurology; 2016 Sep; 87(12):1206-11. PubMed ID: 27558379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased CAIDE dementia risk, cognition, CSF biomarkers, and vascular burden in healthy adults.
    Ecay-Torres M; Estanga A; Tainta M; Izagirre A; Garcia-Sebastian M; Villanua J; Clerigue M; Iriondo A; Urreta I; Arrospide A; Díaz-Mardomingo C; Kivipelto M; Martinez-Lage P
    Neurology; 2018 Jul; 91(3):e217-e226. PubMed ID: 29898969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term dementia risk prediction by the LIBRA score: A 30-year follow-up of the CAIDE study.
    Deckers K; Barbera M; Köhler S; Ngandu T; van Boxtel M; Rusanen M; Laatikainen T; Verhey F; Soininen H; Kivipelto M; Solomon A
    Int J Geriatr Psychiatry; 2020 Feb; 35(2):195-203. PubMed ID: 31736136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.
    de Ruijter W; Westendorp RG; Assendelft WJ; den Elzen WP; de Craen AJ; le Cessie S; Gussekloo J
    BMJ; 2009 Jan; 338():a3083. PubMed ID: 19131384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in CAIDE Dementia Risk Score and Neuroimaging Biomarkers During a 2-Year Multidomain Lifestyle Randomized Controlled Trial: Results of a Post-Hoc Subgroup Analysis.
    Stephen R; Ngandu T; Liu Y; Peltonen M; Antikainen R; Kemppainen N; Laatikainen T; Lötjönen J; Rinne J; Strandberg T; Tuomilehto J; Vanninen R; Soininen H; Kivipelto M; Solomon A;
    J Gerontol A Biol Sci Med Sci; 2021 Jul; 76(8):1407-1414. PubMed ID: 33970268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study.
    van Peet PG; de Craen AJ; Gussekloo J; de Ruijter W
    Age (Dordr); 2014 Jun; 36(3):9660. PubMed ID: 24807464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study.
    Rusanen M; Ngandu T; Laatikainen T; Tuomilehto J; Soininen H; Kivipelto M
    Curr Alzheimer Res; 2013 Jun; 10(5):549-55. PubMed ID: 23566344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midlife stroke risk and cognitive decline: a 10-year follow-up of the Whitehall II cohort study.
    Kaffashian S; Dugravot A; Brunner EJ; Sabia S; Ankri J; Kivimäki M; Singh-Manoux A
    Alzheimers Dement; 2013 Sep; 9(5):572-9. PubMed ID: 23199495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk prediction models for dementia: role of age and cardiometabolic risk factors.
    Fayosse A; Nguyen DP; Dugravot A; Dumurgier J; Tabak AG; Kivimäki M; Sabia S; Singh-Manoux A
    BMC Med; 2020 May; 18(1):107. PubMed ID: 32423410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations among vascular risk factors, neuroimaging biomarkers, and cognition: Preliminary analyses from the Multi-Ethnic Study of Atherosclerosis (MESA).
    Lockhart SN; Schaich CL; Craft S; Sachs BC; Rapp SR; Jung Y; Whitlow CT; Solingapuram Sai KK; Cleveland M; Williams BJ; Burke GL; Bertoni A; Hayden KM; Hughes TM
    Alzheimers Dement; 2022 Apr; 18(4):551-560. PubMed ID: 34482601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and cognitive fitness at age 18 and risk of early-onset dementia.
    Nyberg J; Åberg MA; Schiöler L; Nilsson M; Wallin A; Torén K; Kuhn HG
    Brain; 2014 May; 137(Pt 5):1514-23. PubMed ID: 24604561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular risk factors and cognitive impairment in a stroke-free cohort.
    Unverzagt FW; McClure LA; Wadley VG; Jenny NS; Go RC; Cushman M; Kissela BM; Kelley BJ; Kennedy R; Moy CS; Howard V; Howard G
    Neurology; 2011 Nov; 77(19):1729-36. PubMed ID: 22067959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.